Roundtable for Researchers
Virtual Roundtable: Recordkeeping and Reporting for Government Grants
October 9, 2019, 11:00 am - 12:30 pm EDT Online
George G. Moker, EdD, Managing Director, Director of Government Contracting & Business Development
Ambrosi Donahue Congdon & Co.
Director of Entrepreneurship Programs
Suffolk University - Boston
Alexander Margulis, Ph.D., Chief Operating Officer
Dalfoni Banerjee, Principal Consultant & CEO
3Sixty Pharma Solutions
Congratulations! You’ve received a federal grant!
Before, during, and after your grant period, handling your recordkeeping accurately is an investment of time and management that can save you many thousands of dollars in the long run.
Our experts will walk you through proper grant reporting procedures, helping you stay on top of your federal obligations in real-time while preventing last minute confusion or hassle.
In this session you will learn how to properly track and report on, among other topics:
- Financial Data: Where and how did you spend your money?
- Project Data: What progress has been made?
- Compliance Information: Have you been following all of the proper federal regulations?
Federal funding helps to ignite and sustain countless research projects each year, providing the capital needed to innovate and push a program or idea to the next level. Your ability to comprehensively track and report on your federally funded research is paramount for continued funding decisions in your favor.
About our Speaker:
George G. Moker, EdD, Managing Director, Director of Government Contracting &
Business Development, Ambrosi Donahue Congdon & Co.
Director of Entrepreneurship Programs, Suffolk University - Boston
George Moker has more than 25 years’ experience as a CPA. He has developed training manuals, workshops, and seminars in the record-keeping and reporting compliance areas of government contracting. George earned his Master's degree in business administration (MBA) from Suffolk University, where he currently serves as Director of Entrepreneurship Programs as well as being a member of the entrepreneurship faculty. He has served in senior management positions in the private sector, including roles as Chief Financial Officer and Vice President of Operations in an aerospace support company that provided metrology products and services to the Department of Defense and NASA. George has successfully assisted multiple companies in commercializing and growing their operations.
Grant-Writing Essentials Series
The purpose of this series is to discuss grant-writing experiences for landmark moments on the lab-to-market journey – to show what “good” looks like at key points in the process.
Part 1: NIH SBIR/STTR Grant-Writing Best Practices • Recording • PDF
Part 2: The Commercialization Plan • Recording • PDF
Scroll Down for Additional Sessions
Grant-Writing Essentials Series:
Part 2 - The Commercialization Plan
The focus of this session is the all-important commercialization plan. Our experts share commercialization fundamentals to help you visualize the terrain that you will traverse as your product heads toward market and, potentially, patients.
Any private, public, or government funder/investor will expect you to be fluent in these practices. Your credibility is crucial when seeking funding and this discussion will cover a major aspect of your journey.
- Building a Team around your Innovation
- Patent and Market Research
- Prototyping and Scale-Up
- Competitive Insights
- Feasibility of Market Acceptance
- Operationalization Considerations
- Projecting Milestones
- Budget Considerations
About our Speakers:
Director of Business Development and Outreach, Institute of Biotechnology, Cornell University
Marla Coppolino connects researchers in the life sciences to grants, programs, and resources available through New York’s NYSTAR-supported Center for Advanced Technology at Cornell University. Marla serves as a liaison for researchers at Cornell and New York state biotech companies to collaborate on technologies that show potential for future commercialized biotech products and services.
Douglas Greene, MD
Founder and Chief Consultant, DAGPHAMED
Dr. Greene is a highly-respected thought-leader in medicine and drug development, having held numerous executive-level positions in companies such as Ikaria Pharmaceuticals, Sanofi-Aventis, and Merck. Alongside his founding of DAGPHAMED, Dr. Greene is also Partner and Chief Clinical Advisor to Business Stimulus Consultants LLC and Chief Medical Officer of Neuronasal LLC.
Principal Consultant & CEO, 3Sixty Pharma Solutions
Dalfoni Banerjee is an award-winning, solution-focused entrepreneur. Beginning her career over 25 years ago in academic, pharmaceutical, and biotechnology research laboratories, she went on to lead inspection-readiness efforts, drive clinical research and clinical operations, manage relationships between pharma and key opinion leaders, develop marketing strategies/tactics, and launch new drug products – across 12+ therapeutic categories. Dalfoni is an invited speaker and moderator on a variety of topics, has authored and co-authored several publications, and has received over 30 awards.
A collaborative session with our Community Partner
3Sixty Pharma Solutions
Bringing together our Roundtable for Researchers
and Young Investigators Programs
Douglas Greene, MD, Founder and Chief Consultant, DAGPHAMED
Dalfoni Banerjee, Principal Consultant & CEO, 3Sixty Pharma Solutions
Understanding the SBIR/STTR landscape,
which crosses every federal agency.
How to “operationalize” the grant-writing process,
enhancing the grant-writer’s prospect for success.